Cargando…

Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study

BACKGROUND: The present study sought to investigate how comorbidity burden influences cancer survivors' quality of life (QoL) and the challenges/adaptations during the coronavirus disease 2019 (COVID) pandemic, and to examine how appraisal processes are related to this impact. METHODS: This cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Carolyn E., Rapkin, Bruce D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417288/
https://www.ncbi.nlm.nih.gov/pubmed/37269193
http://dx.doi.org/10.1002/cam4.6212
_version_ 1785087992507924480
author Schwartz, Carolyn E.
Rapkin, Bruce D.
author_facet Schwartz, Carolyn E.
Rapkin, Bruce D.
author_sort Schwartz, Carolyn E.
collection PubMed
description BACKGROUND: The present study sought to investigate how comorbidity burden influences cancer survivors' quality of life (QoL) and the challenges/adaptations during the coronavirus disease 2019 (COVID) pandemic, and to examine how appraisal processes are related to this impact. METHODS: This cross‐sectional study, administered in spring/summer 2020, compared cancer survivors to a general‐population comparison sample. QoL was assessed with standardized tools. COVID‐specific questions included selected items compiled by the US National Institutes of Health, and cognitive appraisal processes were assessed using the QoL Appraisal Profile(v2) Short‐Form. Principal components analysis reduced the number of comparisons. Multivariate analysis of covariance investigated group differences in QoL, COVID‐specific variables, and cognitive‐appraisal processes. Linear regression investigated group differences in COVID‐specific variables as a function of cognitive‐appraisal processes, QoL, demographic covariates, and their interactions. RESULTS: Cancer survivors fared substantially better than non‐cancer participants in QoL and cognitive functioning when they had no other comorbidities, but substantially worse on QoL when they had three or more comorbidities. Cancer survivors with no comorbidities were less likely to feel worried about COVID, less likely to engage in self‐protection, and prioritized engaging in problem‐focused and prosocial actions compared to non‐cancer participants. Conversely, cancer survivors confronted with multiple comorbidities exhibited more proactive self‐protection and experienced more anxiety about the pandemic. CONCLUSION: The impact of having multiple comorbidities in the context of cancer is associated with notable differences in social determinants of health, QoL outcomes, COVID‐specific challenges/adaptations, and appraisal of QoL. These findings provide an empirical basis for implementing appraisal‐based coping interventions.
format Online
Article
Text
id pubmed-10417288
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104172882023-08-12 Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study Schwartz, Carolyn E. Rapkin, Bruce D. Cancer Med RESEARCH ARTICLES BACKGROUND: The present study sought to investigate how comorbidity burden influences cancer survivors' quality of life (QoL) and the challenges/adaptations during the coronavirus disease 2019 (COVID) pandemic, and to examine how appraisal processes are related to this impact. METHODS: This cross‐sectional study, administered in spring/summer 2020, compared cancer survivors to a general‐population comparison sample. QoL was assessed with standardized tools. COVID‐specific questions included selected items compiled by the US National Institutes of Health, and cognitive appraisal processes were assessed using the QoL Appraisal Profile(v2) Short‐Form. Principal components analysis reduced the number of comparisons. Multivariate analysis of covariance investigated group differences in QoL, COVID‐specific variables, and cognitive‐appraisal processes. Linear regression investigated group differences in COVID‐specific variables as a function of cognitive‐appraisal processes, QoL, demographic covariates, and their interactions. RESULTS: Cancer survivors fared substantially better than non‐cancer participants in QoL and cognitive functioning when they had no other comorbidities, but substantially worse on QoL when they had three or more comorbidities. Cancer survivors with no comorbidities were less likely to feel worried about COVID, less likely to engage in self‐protection, and prioritized engaging in problem‐focused and prosocial actions compared to non‐cancer participants. Conversely, cancer survivors confronted with multiple comorbidities exhibited more proactive self‐protection and experienced more anxiety about the pandemic. CONCLUSION: The impact of having multiple comorbidities in the context of cancer is associated with notable differences in social determinants of health, QoL outcomes, COVID‐specific challenges/adaptations, and appraisal of QoL. These findings provide an empirical basis for implementing appraisal‐based coping interventions. John Wiley and Sons Inc. 2023-06-03 /pmc/articles/PMC10417288/ /pubmed/37269193 http://dx.doi.org/10.1002/cam4.6212 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Schwartz, Carolyn E.
Rapkin, Bruce D.
Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study
title Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study
title_full Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study
title_fullStr Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study
title_full_unstemmed Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study
title_short Impact of comorbidities on people with and without cancer early in the COVID‐19 pandemic: An observational study
title_sort impact of comorbidities on people with and without cancer early in the covid‐19 pandemic: an observational study
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417288/
https://www.ncbi.nlm.nih.gov/pubmed/37269193
http://dx.doi.org/10.1002/cam4.6212
work_keys_str_mv AT schwartzcarolyne impactofcomorbiditiesonpeoplewithandwithoutcancerearlyinthecovid19pandemicanobservationalstudy
AT rapkinbruced impactofcomorbiditiesonpeoplewithandwithoutcancerearlyinthecovid19pandemicanobservationalstudy